Literature DB >> 31313973

Effects of Nurse-Led Support Via WeChat, a Smartphone Application, for Breast Cancer Patients After Surgery: A Quasi-Experimental Study.

Qian Wu1,2, Jennifer Kue3, Xiaoping Zhu1, Xiaobing Yin1, Jinxia Jiang4, Jingjuan Chen1, Limin Yang1, Li Zeng1, Xiao Sun1, Xianliang Liu4, Xia Duan1, Yan Shi1.   

Abstract

Background: Women with breast cancer (BC) commonly experience physical and psychosocial symptoms after surgery. Web- and smartphone-based support can significantly improve women's symptoms and quality of life. Social care applications (apps) are widely used in China, but there are few studies on their effectiveness BC support. This study aimed to examine the effects of nurse-led support on the social care app WeChat® (Tencent Holdings Limited, Shenzhen, China) in BC patients after surgery.
Methods: A quasi-experimental study was conducted between June 2015 and August 2015. Sixty patients with BC (30 in the intervention group, 30 in the control group) were enrolled. Subjects in the intervention group participated in a WeChat-based support program (WSP) led by nurses, while subjects in the control group received a follow-up by telephone. Subjects in both groups were evaluated at the time of discharge and at 1, 3, and 6 months of follow-up. Physical well-being status, psychology status, and social support were evaluated.
Results: There were no differences between intervention and control patients at baseline. Physical well-being (p < 0.001), anxiety (p < 0.001), depression (p < 0.001), and support from outside of family (p  = 0.037) were significantly better in the intervention group than in the control group after 6 months. The intervention group showed that physical well-being (p  = 0.036), anxiety (p < 0.001), and depression (p < 0.001) were significantly different from baseline to 6 months of follow-up.
Conclusion: WSP assisted with nurse-led support and had physical, psychological, and social benefits for patients after surgery for BC.

Entities:  

Keywords:  breast neoplasms; mobile phone application; nursing; oncology; smartphone

Mesh:

Year:  2019        PMID: 31313973     DOI: 10.1089/tmj.2018.0293

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  6 in total

Review 1.  Effectiveness of mobile health-based self-management interventions in breast cancer patients: a meta-analysis.

Authors:  Xia Luo; Yuzhen Chen; Jing Chen; Yue Zhang; Mingfang Li; Chenxia Xiong; Jun Yan
Journal:  Support Care Cancer       Date:  2021-09-24       Impact factor: 3.603

Review 2.  Oncology Nursing During a Pandemic: Critical Reflections in the Context of COVID-19.

Authors:  Catherine Paterson; Barbara Gobel; Tracy Gosselin; Pamela J Haylock; Constantina Papadopoulou; Kim Slusser; Anna Rodriguez; Edith Pituskin
Journal:  Semin Oncol Nurs       Date:  2020-04-23       Impact factor: 2.315

3.  Effect of WeChat consultation group on residents staying at home in Sichuan and Chongqing regions during the Coronavirus Disease 2019 (COVID-19) outbreak in China: a cross-sectional study.

Authors:  Xiaolei Hu; Xuejun Li; Yang Lü; Jing Tang; Hai Rong Li; Min Tang
Journal:  BMC Public Health       Date:  2020-11-30       Impact factor: 3.295

Review 4.  Mobile health applications for the care of patients with breast cancer: A scoping review.

Authors:  Tingting Cai; Yueshi Huang; Yuxia Zhang; Zhenqi Lu; Qingmei Huang; Changrong Yuan
Journal:  Int J Nurs Sci       Date:  2021-08-25

5.  Monitoring the Changes of Upper Limb Water in Breast Cancer Patients by Segmental Multi-Frequency Bioelectrical Impedance Analysis.

Authors:  Lijuan Zhang; Huizhen Zhang; Xiaohang Liu; Qiaoling Zhong; Qinghua Luo; Yiheng Zhang; Ni Gong; Huiying Qin; Anli Yang
Journal:  Med Sci Monit       Date:  2020-10-31

6.  The effectiveness of a WeChat-based multimodal nursing program for women with breast cancer: A randomized controlled trial protocol.

Authors:  Na Zhao; Fang Yin; Xiaofang Wu; Yuxia Zhong
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.